Developer of vascular interventional embolization products intended to meet clinical needs. Hiwemed is based in Suzhou, China and was founded in 2021.
Team — not yet on record
No current team members for Hiwemed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hiwemed with a free account
- ·Watch Hiwemed: the Monday email on marks, rounds and moves
